Fan Liangwu and others have become "benchmarks" for workers in Baoan Town"
Release time:
2020-08-14
Fan Liangwu and others became "benchmarks" for employees in Baoan Town
News 4# July 25 , Baoan Town, where daye peak cement company is located, held a conference to commend the leaders of "enterprise industry pacesetters" and "two innovations. Daye Jianfeng Fan Liangwu, Huang Yanming and Feng Junwen were commended.
In order to promote the overall quality of the staff and workers in Baoan Town, create an atmosphere of advocating advanced, loving and dedicated, united and striving, pioneering and enterprising among the staff and workers, and stimulate the enthusiasm of the staff and workers, the Baoan Town Federation of Trade Unions has carried out activities to select "enterprise industry pacesetters" and "two innovations" leaders in the town as a benchmark for the staff and workers in the town to learn. After layers of selection, Daye Jianfeng Fan Liangwu and Huang Yanming were rated as "enterprise industry pacesetters", and Feng Junwen was rated as the leader of "two innovations.
Fan Liangwu is the manager of Daye Peak Quality Control Department. Over the years, he has made remarkable achievements in raw material ingredient optimization, material cost control, cement quality control, etc. He has won honors such as outstanding scientific and technological workers of the group company, and the Quality Control Department has also been rated as an advanced department by the group company. Huang Yanming is an equipment engineer of Daye Peak. He has presided over and participated in many technical reforms such as mineral powder addition, cement grinding tail cooling, loading lane, etc. He was rated as an outstanding employee of the Group Company for his outstanding achievements. Feng Junwen, deputy manager of Daye Peak Manufacturing Department, has many years of electrical work experience, and is responsible for a number of technical transformations that have saved a lot of energy consumption and reduced production costs for the enterprise.
At the commendation meeting, the Baoan Town Federation of Trade Unions hopes that the commended comrades can be modest and prudent, guard against arrogance and rashness, make persistent efforts, and make further achievements in future work; call on all enterprises and institutions in the town to take advanced as an example and make new contributions to promoting the social development of Baoan Town. (Zhu Yong)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31